Expensive drug driving up Medicare expenditures without evidence of greater efficacy
Medicare spent more than $1 billion over a five-year period on a high-priced drug that has not been proven more effective for a collection of inflammatory conditions than much less expensive corticosteroids, research by the ...
Sep 11, 2017
0
0